Disease recurrence ≤ 12 months (EEC stage) · women having endometriosis surgery
It is very uncertain whether postsurgical medical therapy changes disease recurrence ≤ 12 months (EEC stage) compared with placebo or no medical therapy (very low certainty).
1 finding from 1 review
Pregnancy rate · women having endometriosis surgery
Postsurgical medical therapy probably leads to higher pregnancy rate (dichotomous) compared with placebo or no medical therapy (moderate certainty).
1 finding from 1 review
Pelvic pain · women having endometriosis surgery
1 finding from 1 review
Pain recurrence (dichotomous) Pain recurrence ≤ 12 months · women having endometriosis surgery
Postsurgical medical therapy may leads to lower pain recurrence (dichotomous) Pain recurrence ≤ 12 months compared with placebo or no medical therapy (low certainty).
1 finding from 1 review
Disease recurrence at 12 months – total (AFS score) · women having endometriosis surgery
1 finding from 1 review
Surgical technique vs No treatment
Outcome not reported · People of any age with oro-antral communications, fistulae, or both caused by dental procedures
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
0 studies
No studies found
All‐cause mortality at 30 days · people with cirrhotic portal hypertension
It is very uncertain whether surgical portosystemic shunts changes all‐cause mortality at 30 days compared with transjugular intrahepatic portosystemic shunt (TIPS) (very low certainty).
1 finding from 1 review
All‐cause mortality at 5 years · people with cirrhotic portal hypertension
It is very uncertain whether surgical portosystemic shunts changes all‐cause mortality at 5 years compared with transjugular intrahepatic portosystemic shunt (TIPS) (very low certainty).
1 finding from 1 review
Number of participants with Variceal rebleeding episodes at 30 days · people with cirrhotic portal hypertension
It is very uncertain whether surgical portosystemic shunts changes number of participants with Variceal rebleeding episodes at 30 days compared with transjugular intrahepatic portosystemic shunt (TIPS) (very low certainty).
1 finding from 1 review
Reintervention Number of women with reintervention · people with cirrhotic portal hypertension
It is very uncertain whether surgical portosystemic shunts changes number of participants with reintervention at 5 years compared with transjugular intrahepatic portosystemic shunt (TIPS) (very low certainty).
1 finding from 1 review
Irreversible shunt occlusion at 5 years · people with cirrhotic portal hypertension
It is very uncertain whether surgical portosystemic shunts changes irreversible shunt occlusion at 5 years compared with transjugular intrahepatic portosystemic shunt (TIPS) (very low certainty).
1 finding from 1 review
Encephalopathy · people with cirrhotic portal hypertension
It is very uncertain whether surgical portosystemic shunts changes number of participants with encephalopathy at 5 years compared with transjugular intrahepatic portosystemic shunt (TIPS) (very low certainty).
1 finding from 1 review
Health‐related quality of life · people with cirrhotic portal hypertension
1 finding from 1 review
All‐cause mortality · people with hepatosplenic schistosomiasis
It is very uncertain whether surgical portosystemic shunts changes all‐cause mortality compared with devascularisation with splenectomy (very low certainty).
1 finding from 1 review
Serious adverse events · people with hepatosplenic schistosomiasis
It is very uncertain whether surgical portosystemic shunts changes serious adverse events compared with devascularisation with splenectomy (very low certainty).
1 finding from 1 review
Quality of life · people with hepatosplenic schistosomiasis
1 finding from 1 review
Rebleeding · people with hepatosplenic schistosomiasis
It is very uncertain whether surgical portosystemic shunts changes variceal rebleeding rate compared with devascularisation with splenectomy (very low certainty).
1 finding from 1 review
Encephalopathy · people with hepatosplenic schistosomiasis
It is very uncertain whether surgical portosystemic shunts changes encephalopathy compared with devascularisation with splenectomy (very low certainty).
1 finding from 1 review
Ascites · people with hepatosplenic schistosomiasis
It is very uncertain whether surgical portosystemic shunts changes ascites compared with devascularisation with splenectomy (very low certainty).
1 finding from 1 review
Any re‐intervention · people with hepatosplenic schistosomiasis
It is very uncertain whether surgical portosystemic shunts changes any re‐intervention compared with devascularisation with splenectomy (very low certainty).
1 finding from 1 review